Protein kinase C-related kinase (PKN/PRK). Potential key-role for PKN1 in protection of hypoxic neurons

Current Neuropharmacology

Volumn 12, Issue 3, 2014, Pages 213-218

  Thauerer, Bettina ^a   zur Nedden, Stephanie ^a   Baier Bitterlich, Gabriele ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Hypoxia; Neuroprotection; PKN; PRK; Protein kinase C related kinase; Purine nucleosides; Review

Indexed keywords

HERMES ANTIGEN; NERVE GROWTH FACTOR; NEUROTROPHIN; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE C; PROTEIN KINASE C RELATED KINASE 1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN ISCHEMIA; CELL MIGRATION; CELL VIABILITY; DEREGULATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HYPOXIA; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

EID: 84924206057     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X11666131225000518     Document Type: Article

References (80)

1. Mukai, H., Ono, Y. A novel protein kinase with leucine zipper-like sequences: its catalytic domain is highly homologous to that of protein kinase C. Biochem. Biophys. Res. Comm., 1994, 199(2), 897-904. DOI: http://dx.doi.org/10.1006/bbrc.1994.1313
2. Palmer, R.H., Ridden, J., Parker, P.J. Cloning and expression patterns of two members of a novel protein-kinase-C-related kinase family. Eur. J. Biochem. FEBS, 1995, 227(1-2), 344-51. DOI: http://dx.doi.org/10.1111/j.1432-1033.1995.tb20395.x
3. Taylor, S.S., Radzio-Andzelm, E. Three protein kinase structures define a common motif. Structure, 1994, 2(5), 345-55.
4. Mellor, H., Parker, P.J. The extended protein kinase C superfamily. Biochem. J., 1998, 332(Pt 2), 281-92. PubMed ID: 9601053
5. Mukai, H. The structure and function of PKN, a protein kinase having a catalytic domain homologous to that of PKC. J. Biochem. (Tokyo), 2003, 133(1), 17-27. DOI: http://dx.doi.org/10.1093/jb/ mvg019
6. Kitagawa, M., Mukai, H., Shibata, H., Ono, Y. Purification and characterization of a fatty acid-activated protein kinase (PKN) from rat testis. Biochem. J., 1995, 310 (Pt 2), 657-64. PubMed ID: 7654208.
7. Oishi, K., Mukai, H., Shibata, H., Takahashi, M., Ona, Y. Identification and characterization of PKNbeta, a novel isoform of protein kinase PKN: expression and arachidonic acid dependency are different from those of PKNalpha. Biochem. Biophys. Res. Comm., 1999, 261(3), 808-14. DOI: http://dx.doi.org/10.1006/ bbrc.1999.1116
8. Lachmann, S., Jevons, A., De Rycker, M., Casamassima, A., Radtke, S., Collazos, A., Parker P.J. Regulatory domain selectivity in the cell-type specific PKN-dependence of cell migration. PloS one, 2011, 6(7), e21732. DOI: http://dx.doi.org/10.1371/journal. pone.0021732
9. Mukai, H., Kitagawa, M., Shibata, H., Takanaga, H., Mori, K., Shimakawa, M., Miyahara, M., Hirao, K., Ono, Y. Activation of PKN, a novel 120-kDa protein kinase with leucine zipper-like sequences, by unsaturated fatty acids and by limited proteolysis. Biochem. Biophys. Res. Comm.,1994, 204(1), 348-56. DOI: http://dx.doi.org/10.1006/bbrc.1994.2466
10. Hashimoto, T., Mukai H., Kawamata, T., Taniguchi, T., Ono, Y., Tanaka, C. Localization of PKN mRNA in the rat brain. Brain Res. Mol. Brain Res., 1998, 59(2), 143-53. DOI: http://dx.doi.org/ 10.1016/S0169-328X(98)00155-7
11. Quilliam, L.A., Lambert, Q.T., Mickelson-Young, L.A., Westwick, J.K., Sparks, A.B., Kay, B.K., Jenkins, N.A., Gilbert, D.J., Copeland, N.G., Der, C.J. Isolation of a NCK-associated kinase, PRK2, an SH3-binding protein and potential effector of Rho protein signaling. J. Biol. Chem., 1996, 271(46), 28772-6. DOI: http://dx.doi.org/10.1074/jbc.271.46.28772
12. Palmer, R.H., Dekker, L.V., Woscholski, R., Le Good, J.A., Gigg, R., Parker, P.J. Activation of PRK1 by phosphatidylinositol 4,5- bisphosphate and phosphatidylinositol 3,4,5-trisphosphate. A comparison with protein kinase C isotypes. J. Biol. Chem., 1995, 270(38), 22412-6. DOI: http://dx.doi.org/10.1074/jbc.270.38.22412
13. Gudi, T., Chen, J.C., Casteel, D.E., Seasholtz, T.M., Boss, G.R., Pilz, R.B. cGMP-dependent protein kinase inhibits serum-response element-dependent transcription by inhibiting rho activation and functions. J. Biol. Chem., 2002, 277(40), 37382-93. DOI: http://dx. doi.org/10.1074/jbc.M204491200
14. Mukai, H., Miyahara, M., Sunakawa, H., Shibata, H., Toshimori, M., Kitagawa, M., Shimakawa, M., Takanaga, H., Ono, Y. Translocation of PKN from the cytosol to the nucleus induced by stresses. Proc. Natl. Acad. Sci. U. S.A., 1996, 93(19), 10195-9. DOI: http://dx.doi.org/10.1073/pnas.93.19.10195
15. Sihag, R.K., Inagaki, M., Yamaguchi, T., Shea, T.B., Pant, H.C. Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments. Exp. Cell Res., 2007, 313(10) 2098-109. DOI: http://dx.doi.org/10.1016/j.yexcr.2007.04.010
16. Thauerer, B., zur Nedden, S., Baier-Bitterlich, G. Vital role of protein kinase C-related kinase in the formation and stability of neurites during hypoxia. J. Neurochem., 2010, 113(2), 432-46. DOI: http://dx.doi.org/10.1111/j.1471-4159.2010.06624.x
17. Volonte, C., Greene, L.A. Nerve growth factor-activated protein kinase N. Characterization and rapid near homogeneity purification by nucleotide affinity-exchange chromatography. J. Biol. Chem., 1992, 267 30, 21663-70. PMID: 1400478
18. Manser, C., Stevenson, A., Banner, S., Davies, J., Tudor, E.L., Ono, Y., Leigh, P.N., McLoughlin, D.M., Shaw C.E., Miller, C.C. Deregulation of PKN1 activity disrupts neurofilament organisation and axonal transport. FEBS Lett., 2008, 582(15), 2303-8. DOI: http://dx.doi.org/10.1016/j.febslet.2008.05.034
19. Xiao, S., McLean, J., Robertson, J. Neuronal intermediate filaments and ALS: a new look at an old question. Biochim. et Biophys. Act., 2006, 1762(11-12), 1001-12. DOI: http://dx.doi.org/10.1016/ j.bbadis.2006.09.003
20. Kawamata, T., Taniguchi, T., Mukai, H., Kitagawa M., Hashimoto, T., Maeda, K., Ono, Y., Tanaka, C. A protein kinase, PKN, accumulates in Alzheimer neurofibrillary tangles and associated endoplasmic reticulum-derived vesicles and phosphorylates tau protein. J. Neurosci., 1998, 18(18), 7402-10. PMID: 9736660
21. Taniguchi, T., Kawamata, T., Mukai, H., Hasegawa, H., Isagawa, T., Yasuda M., Hashimoto, T., Terashima, A., Nakai, M., Mori, H., Ono Y., Tanaka C. Phosphorylation of tau is regulated by PKN. J. Biol. Chem., 2001, 276(13), 10025-31. DOI: http://dx.doi.org/10.1074/ jbc.M007427200
22. Tomaselli, B., Podhraski, V., Böck, G., Baier-Bitterlich, G. Early cellular responses of purine nucleoside-mediated protection of hypoxia-induced injuries of neuronal PC12 cells. Am. J. Biochem. Biotechnol., 2005, 2(3), 161-167. DOI: http://dx.doi.org/10.3844/ ajbbsp.2005.160.166
23. Thauerer, B., zur Nedden, S., Baier-Bitterlich, G. Vital role of protein kinase C-related kinase in the formation and stability of neurites during hypoxia. J. Neurochem., 2010, 113(2), 432-46. DOI: http://dx.doi.org/10.1111/j.1471-4159.2010.06624.x
24. Yoshinaga, C., Mukai, H., Toshimori, M., Miyamoto, M., Ono, Y. Mutational analysis of the regulatory mechanism of PKN: the regulatory region of PKN contains an arachidonic acid-sensitive autoinhibitory domain. J. Biochem., 1999, 126(3), 475-84. DOI: http://dx.doi.org/10.1093/oxfordjournals.jbchem.a022476
25. Bauer, A.F., Sonzogni, S., Meyer, L., Zeuzem, S., Piiper, A., Biondi, R.M., Neimanis, S. Regulation of protein kinase C-related protein kinase 2 (PRK2) by an intermolecular PRK2-PRK2 interaction mediated by Its N-terminal domain. J. Biol. Chem., 2012, 287(24), 20590-602. DOI: http://dx.doi.org/10.1074/jbc. M111.327437
26. Collazos, A., Michael N., Whelan, R.D., Kelly, G., Mellor, H., Pang, L.C., Totty N., Parker P.J. Site recognition and substrate screens for PKN family proteins. Biochem. J., 2011, 438(3), 535- 43. DOI: http://dx.doi.org/10.1042/BJ20110521
27. Maesaki, R., Ihara, K., Shimizu, T., Kuroda, S., Kaibuchi, K., Hakoshima, T. The structural basis of Rho effector recognition revealed by the crystal structure of human RhoA complexed with the effector domain of PKN/PRK1. Mol. Cell, 1999, 4(5), 793-803. DOI: http://dx.doi.org/10.1016/S1097-2765(00)80389-5
28. Amano, M., Chihara, K., Nakamura, N., Kaneko, T., Matsuura, Y., Kaibuchi, K. Identification of a putative target for Rho as the serine-threonine kinase protein kinase N. Science, 1996, 271(5249), 648-50. DOI: http://dx.doi.org/10.1126/science.271.5249.648
29. Watanabe, G., Saito, Y., Madaule, P., Ishizaki, T., Fujisawa, K., Morii, N., Mukai, H., Ono, Y., Kakizuka, A., Narumiya, S. Protein kinase N (PKN) and PKN-related protein rhophilin as targets of small GTPase Rho. Science, 1996, 271(5249), 645-8. DOI: http:// dx.doi.org/10.1126/science.271.5249.645
30. Flynn, P., Mellor, H., Palmer, R., Panayotou, G., Parker, P.J. Multiple interactions of PRK1 with RhoA. Functional assignment of the Hr1 repeat motif. J. Biol. Chem., 1998, 273(5), 2698-705. DOI: http://dx.doi.org/10.1074/jbc.273.5.2698
31. Vincent, S., Settleman, J. The PRK2 kinase is a potential effector target of both Rho and Rac GTPases and regulates actin cytoskeletal organization. Mol. Cell Biol., 1997, 17(4), 2247-56. PMID:9121475
32. Lu, Y., Settleman, J. The Drosophila Pkn protein kinase is a Rho/Rac effector target required for dorsal closure during embryogenesis. Genes Dev., 1999, 13(9), 1168-80. DOI: http://dx.doi.org/10.1101/ gad.13.9.1168
33. Modha, R., Campbell L.J., Nietlispach, D., Buhecha, H.R., Owen, D., Mott, H.R. The Rac1 polybasic region is required for interaction with its effector PRK1. J. Biol. Chem., 2008, 283(3), 1492-500. DOI: http://dx.doi.org/10.1074/jbc.M706760200
34. Unsal-Kacmaz, K., Ragunathan, S., Rosfjord, E., Dann, S., Upeslacis, E., Grillo, M., Hernandez, R., Mack, F., Klippel, A. The interaction of PKN3 with RhoC promotes malignant growth. Mol. Oncol., 2012, 6(3), p. 284-98. DOI: http://dx.doi.org/10.1016/ j.molonc.2011.12.001
35. Blumenstein, L., Ahmadian, M.R. Models of the cooperative mechanism for Rho effector recognition: implications for RhoAmediated effector activation. J. Biol. Chem., 2004, 279(51), 53419- 26. DOI: http://dx.doi.org/10.1074/jbc.M409551200
36. Owen, D., Lowe, P.N., Nietlispach, D., Brosnan, C.E., Chirgadze, D.Y., Parker, P.J., Blundell, T.L., Mott, H.R. Molecular dissection of the interaction between the small G proteins Rac1 and RhoA and protein kinase C-related kinase 1 (PRK1). J. Biol. Chem., 2003, 278(50), 50578-87. DOI: http://dx.doi.org/10.1074/jbc. M304313200
37. Flynn, P., Mellor, H., Palmer, R., Panayotou, G., Parker P.J. Rho GTPase control of protein kinase C-related protein kinase activation by 3-phosphoinositide-dependent protein kinase. J. Biol. Chem., 2000, 275(15), 11064-70. DOI: http://dx.doi.org/10.1074/ jbc.275.15.11064
38. Wallace, S.W., Magalhaes A., Hall A. The Rho target PRK2 regulates apical junction formation in human bronchial epithelial cells. Mol. Cell. Biol., 2011, 31(1), 81-91. DOI: http://dx.doi.org/ 10.1128/MCB.01001-10
39. Gabrielli, B., Wettenhall, R.E., Kemp, B.E., Quinn, M., Bizonova, L. Phosphorylation of ribosomal protein S6 and a peptide analogue of S6 by a protease-activated kinase isolated from rat liver. FEBS Lett., 1984, 175(2), 219-26. DOI: http://dx.doi.org/10.1016/0014- 5793(84)80740-1
40. Shiga, K., Takayama K., Futaki S., Hutti J.E., Cantley L.C., Ueki, K., Ono, Y., Mukai, H. Development of an intracellularly acting inhibitory peptide selective for PKN. Biochem. J., 2010, 425(2), 445-543. DOI: http://dx.doi.org/10.1042/BJ20090380
41. Shibata, H., Oishi K., Yamagiwa, A., Matsumoto, M., Mukai, H., Ono, Y. Characterization of the interaction between RhoA and the amino-terminal region of PKN. FEBS Lett., 1996, 385(3), 221-4. DOI: http://dx.doi.org/10.1016/0014-5793(96)00385-7
42. Kitagawa, M., Shibata, H., Toshimori, M., Mukai H., Ono, Y. The role of the unique motifs in the amino-terminal region of PKN on its enzymatic activity. Biochem. Biophys. Res. Comm., 1996, 220(3), 963-8. DOI: http://dx.doi.org/10.1006/bbrc.1996.0515
43. Morrice, N.A., Fecondo, J., Wettenhall, R.E. Differential effects of fatty acid and phospholipid activators on the catalytic activities of a structurally novel protein kinase from rat liver. FEBS Lett., 1994, 351(2), 171-5. DOI: http://dx.doi.org/10.1016/0014-5793(94) 00854-X
44. Palmer, R.H., Parker, P.J. Expression, purification and characterization of the ubiquitous protein kinase C-related kinase 1. Biochem. J., 1995, 309 (Pt 1), 315-20. PMID: 7619073
45. Takahashi, M., Mukai, H., Toshimori, M., Miyamoto, M., Ono, Y. Proteolytic activation of PKN by caspase-3 or related protease during apoptosis. Proc. Natl. Acad. Sci. U. S. A., 1998, 95(20), 11566-71. DOI: http://dx.doi.org/10.1073/pnas.95.20.11566
46. Ueyama, T., Ren, Y., Sakai, N., Takahashi, M., Ono, Y., Kondoh, T., Tamaki, N., Saito, N. Generation of a constitutively active fragment of PKN in microglia/macrophages after middle cerebral artery occlusion in rats. J. Neurochem., 2001, 79(4), 903-13.
47. Lim, W.G., Zhu, Y., Wang, C.H., Tan, B.J., Armstrong, J.S., Dokland, T., Yang, H., Zhu, Y.Z., Teo T.S., Duan, W. The last five amino acid residues at the C-terminus of PRK1/PKN is essential for full lipid responsiveness. Cell. Signal., 2005, 17(9), 1084-97. DOI: http://dx.doi.org/10.1016/j.cellsig.2004.12.003
48. Yu, W., Liu, J., Morrice, N.A., Wettenhall, R.E. Isolation and characterization of a structural homologue of human PRK2 from rat liver. Distinguishing substrate and lipid activator specificities. J. Biol. Chem., 1997, 272(15), 10030-4.
49. Metzger, E., Muller, J.M., Ferrari, S., Buettner, R., Schule, R. A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer. EMBO J., 2003, 22(2), 270-80. DOI: http://dx.doi.org/10.1093/emboj/cdg023
50. Metzger, E., Yin, N., Wissmann, M., Kunowska, N., Fischer, K., Friedrichs, N., Patnaik, D., Higgins, J.M., Potier, N., Scheidtmann, K.H., Buettner, R., Schule R. Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation. Nat. Cell Biol., 2008, 10(1), 53-60. DOI: http://dx.doi. org/10.1093/emboj/cdg023
51. Bourguignon, L.Y., Gilad, E., Peyrollier, K., Brightman, A., Swanson R.A. Hyaluronan-CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes. J. Neurochem., 2007, 101(4), 1002-17. DOI: http://dx.doi.org/10.1111/j.1471-4159.2007. 04485.x
52. Leenders, F., Mopert, K., Schmiedeknecht, A., Santel, A., Czauderna, F., Aleku, M., Penschuck S., Dames, S., Sternberger, M., Rohl, T., Wellmann, A., Arnold, W., Giese, K., Kaufmann, J., Klippel, A. PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase. EMBO J., 2004, 23(16), 3303-13. DOI: http://dx.doi.org/10.1038/sj.emboj.7600345
53. Gotoh, Y., Oishi, K., Shibata, H., Yamagiwa, A., Isagawa, T., Nishimura, T., Goyama E., Takahashi, M., Mukai, H., Ono, Y. Protein kinase PKN1 associates with TRAF2 and is involved in TRAF2-NF-kappaB signaling pathway. Biochem. Biophys. Res. Comm., 2004, 314(3), 688-94. DOI: http://dx.doi.org/10.1016/ j.bbrc.2003.12.148
54. Shibata, H., Oishi, K., Yamagiwa, A., Matsumoto, M., Mukai, H., Ono Y. PKNbeta interacts with the SH3 domains of Graf and a novel Graf related protein, Graf2, which are GTPase activating proteins for Rho family. J. Biochem., 2001, 130(1), 23-31. DOI: http://dx.doi.org/10.1093/oxfordjournals.jbchem.a002958
55. Zhu, Y., Stolz D.B., Guo F., Ross M.A., Watkins S.C., Tan B.J., Qi R.Z., Manser E., Li Q.T., Bay B.H., Teo T.S., Duan W. Signaling via a novel integral plasma membrane pool of a serine/threonine protein kinase PRK1 in mammalian cells. FASEB J., 2004, 18(14), 1722-4. DOI: http://dx.doi.org/10.1096/fj.04-1876fje
56. Amano, M., Mukai, H., Ono Y., Chihara, K., Matsui, T., Hamajima, Y., Okawa, K., Iwamatsu, A., Kaibuchi, K. Identification of a putative target for Rho as the serine-threonine kinase protein kinase N. Science, 1996, 271, 648-50. DOI: http://dx.doi.org/10.1126/science.271.5249.648
57. Davies, S.P., Reddy, H., Caivano, M., Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J., 2000, 351(Pt 1), 95-105. DOI: http://dx.doi.org/10.1042/0264-6021:3510095
58. Schmidt, A., Durgan, J., Magalhaes, A., Hall, A. Rho GTPases regulate PRK2/PKN2 to control entry into mitosis and exit from cytokinesis. EMBO J., 2007, 26, 1624-36. DOI: http://dx.doi.org/ 10.1038/sj.emboj.7601637
59. Gampel, A., Parker, P.J., Mellor, H. Regulation of epidermal growth factor receptor traffic by the small GTPase rhoB. Curr. Biol., 1999, 9(17), 955-8.
60. Torbett, N.E., Casamassima, A., Parker, P.J. Hyperosmotic-induced protein kinase N 1 activation in a vesicular compartment is dependent upon Rac1 and 3-phosphoinositide-dependent kinase 1. J. Biol. Chem., 2003, 278(34), 32344-51. DOI: http://dx.doi.org/ 10.1074/jbc.M303532200
61. Takagi, H., Hsu C.P., Kajimoto K., Shao D., Yang Y., Maejima Y., Zhai P., Yehia G., Yamada C., Zablocki D., Sadoshima J. Activation of PKN mediates survival of cardiac myocytes in the heart during ischemia/reperfusion. Circulation Res., 2010, 107(5), 642-9. DOI: http://dx.doi.org/10.1161/CIRCRESAHA.110.217554
62. Kajimoto, K., Shao, D., Takagi, H., Maceri, G., Zablocki, D., Mukai, H., Ono, Y., Sadoshima, J. Hypotonic swelling-induced activation of PKN1 mediates cell survival in cardiac myocytes. American journal of physiology. Heart Circulatory Physiol., 2011, 300(1), H191-200. DOI: http://dx.doi.org/10.1152/ajpheart.00232.2010
63. Marinissen, M.J., Chiariello, M., Gutkind, J.S. Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway. Genes Dev., 2001, 15(5), 535-53. PMID:11238375
64. Calautti, E., Grossi M., Mammucari, C., Aoyama, Y., Pirro M., Ono, Y., Li J., Dotto, G.P. Fyn tyrosine kinase is a downstream mediator of Rho/PRK2 function in keratinocyte cell-cell adhesion. J. Cell Biol., 2002, 156(1), 137-48. DOI: http://dx.doi.org/10.1083/ jcb.200105140
65. Aleku, M., Schulz P., Keil O., Santel A., Schaeper U., Dieckhoff B., Janke O., Endruschat J., Durieux B., Roder N., Loffler K., Lange C., Fechtner M., Mopert K., Fisch G., Dames S., Arnold W., Jochims K., Giese K., Wiedenmann B., Scholz A., Kaufmann J. Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression. Cancer Res., 2008, 68(23), 9788-98. DOI: http://dx.doi.org/10.1158/0008-5472.CAN- 08-2428
66. Santel, A., Aleku, M., Roder, N., Mopert, K., Durieux B., Janke, O., Keil O., Endruschat J., Dames, S., Lange, C., Eisermann, M., Loffler K., Fechtner, M., Fisch, G., Vank, C., Schaeper U., Giese K., Kaufmann, J. Atu027 prevents pulmonary metastasis in experimental and spontaneous mouse metastasis models. Clin. Cancer Res., 2010, 16(22), 5469-80. DOI: http://dx.doi.org/ 10.1158/1078-0432.CCR-10-1994
67. Williamson, T.L., Cleveland, D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci., 1999, 2(1), 50-6. PMID:10195180
68. Collard, J.F., Cote F., Julien J.P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature, 1995, 375(6526), 61-4. DOI: http://dx.doi.org/10.1038/375061a0
69. Zhang, B., Tu, P., Abtahian, F., Trojanowski, J.Q., Lee, V.M. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J. Cell Biol., 1997, 139(5), 1307-15. DOI: http://dx.doi. org/10.1083/jcb.139.5.1307
70. Thauerer, B., S. zur Nedden, S., Baier-Bitterlich, G. Purine nucleosides: endogenous neuroprotectants in hypoxic brain. J. Neurochem., 2012, 121(3), 329-42. DOI: http://dx.doi.org/10.1111/ j.1471-4159.2012.07692.x
71. zur Nedden, S., Tomaselli B., Baier-Bitterlich G. HIF-1 alpha is an essential effector for purine nucleoside-mediated neuroprotection against hypoxia in PC12 cells and primary cerebellar granule neurons. J. Neurochem., 2008, 105(5), 1901-14. DOI: http://dx.doi. org/10.1111/j.1471-4159.2008.05275.x
72. Rudolphi, K.A., Schubert, P., Parkinson, F., Fredholm, B.B. Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol. Sci., 1992, 13(12), 439-45. PMID: 1293870
73. Sweeney, M.I. Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity. Neurosci. Biobehav. Rev., 1997, 21(2), 207-17. PMID: 9062944
74. von Lubitz, D.K. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? Eur. J. Pharmacol., 1999, 371(1), 85-102. PMID: 10355598
75. Tomaselli, B., Nedden, S.Z., Podhraski, V., Baier-Bitterlich, G. p42/44 MAPK is an essential effector for purine nucleosidemediated neuroprotection of hypoxic PC12 cells and primary cerebellar granule neurons. Mol. Cell. Neurosci., 2008, 38(4), 559- 68. DOI: http://dx.doi.org/10.1016/j.mcn.2008.05.004
76. Tomaselli, B., Podhraski, V., Heftberger, V., Böck, G., Baier- Bitterlich, G. Purine nucleoside-mediated protection of chemical hypoxia-induced neuronal injuries involves p42/44 MAPK activation. Neurochem. Int., 2005, 46(7), 513-21. DOI: http://dx.doi.org/10. 1016/j.mcn.2008.05.004
77. Bocklinger, K., Tomaselli, B., Heftberger, V., Podhraski, V., Bandtlow, C., Baier-Bitterlich, G. Purine nucleosides support the neurite outgrowth of primary rat cerebellar granule cells after hypoxia. Eur. J. Cell Biol., 2004, 83(2), 51-4. PMID: 15146976
78. Heftberger, V., Tomaselli, B., Podhraski, V., Baier-Bitterlich, G. Purine Nucleoside Mediated Protection of Primary Cerebellar Granule Cells after Hypoxic Insult. In: Foc. on Neurochem. Res., Nova Science Publ. 2005, pp1-19.
79. Tomaselli, B., Nedden, S.Z., Podhraski, V., Baier-Bitterlich, G. p42/44 MAPK is an essential effector for purine nucleosidemediated neuroprotection of hypoxic PC12 cells and primary cerebellar granule neurons. Mol. Cell. Neurosci., 2008, 38(4), 559- 68. DOI: http://dx.doi.org/10.1016/j.mcn.2008.05.004
80. Mukai, H., Toshimori, M., Shibata, H., Takanaga, H., Kitagawa, M., Miyahara M., Shimakawa M., Ono, Y. Interaction of PKN with alpha-actinin. J. Biol. Chem., 1997, 272(8), 4740-6. DOI: http://dx. doi.org/10.1074/jbc.272.8.4740